Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Moscow will ban building apartments with an area of less than 28 square meters

5/16/24 PIKK

Moscow will ban building apartments with an area of less than 28 square meters

5/16/24 SMLT

Sovcombank to increase free float from 5% to 10%

5/16/24 SVCB

Sovcombank reports for the first quarter of 2024

5/16/24 SVCB

"Softline" showed a three-fold increase in profit in the first quarter

5/16/24 SOFL

The total area of the Magnit network exceeded 10 million square meters

5/16/24 MGNT

Magnit reports for 2023

5/16/24 MGNT

Board of Directors of Rosseti Centere recommended that dividends be paid for 2023

5/16/24 MRKC

Shareholders of Positive Technologies Group approved dividends for march 2024

5/15/24 POSI

Board of Directors of Surgutneftegaz recommended that dividends be paid for 2023

5/15/24 SNGS